KR20190063512A - Method and kit for diagnosis coronavirus using real-time PCR - Google Patents
Method and kit for diagnosis coronavirus using real-time PCR Download PDFInfo
- Publication number
- KR20190063512A KR20190063512A KR1020170162353A KR20170162353A KR20190063512A KR 20190063512 A KR20190063512 A KR 20190063512A KR 1020170162353 A KR1020170162353 A KR 1020170162353A KR 20170162353 A KR20170162353 A KR 20170162353A KR 20190063512 A KR20190063512 A KR 20190063512A
- Authority
- KR
- South Korea
- Prior art keywords
- coronavirus
- real
- time pcr
- kit
- present
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 리얼타임 PCR을 이용하여 코로나바이러스를 검출하는 키트 및 방법에 관한 것으로 보사 상세하게는 검출대상이 되는 코로나바이러스를 다른 바이러스와 교차반응이 없이 간단하면서도 신속하게 검사하는 키트 및 방법에 관한 것이다. The present invention relates to kits and methods for detecting coronavirus using real-time PCR, and more particularly, to kits and methods for simply and rapidly inspecting a coronavirus to be detected without cross-reacting with other viruses .
코로나바이러스는 다양한 숙주를 감염시킬 수 있으며 각각의 숙주에 특이적이다. 하지만 일부 코로나바이러스의 경우 종범위를 벗어나 다른 종을 숙주로 증식할 수 있으며, 새로운 숙주는 해당하는 코로나바이러스에 대한 면역이 이루어지지 않아 효과적으로 방어를 하지 못해 큰 문제를 야기할 수 있다. Coronaviruses can infect a variety of hosts and are specific for each host. However, some coronaviruses can propagate to other host species outside of the species range, and new hosts can cause serious problems because they can not effectively defend against the corresponding coronaviruses.
최근 SARA, MERS 등 신종 코로나바이러스가 사람에게 감염되어 큰 문제가 발생하여 이러한 신종 코로나바이러스에 대한 적절한 진단법이 개발되어야 한다.Recently, new diagnostic methods for these new coronaviruses should be developed due to the serious problems caused by infection with new corona viruses such as SARA and MERS.
본 발명은 리얼타임 PCR을 이용하여 검출대상이 되는 코로나바이러스를 다른 바이러스와 미생물과 교차반응이 없이 간단하면서도 신속하게 검사하는 키트 및 방법을 제공하는데 그 목적이 있다. It is an object of the present invention to provide a kit and method for simply and rapidly inspecting a coronavirus to be detected using real-time PCR without cross-reacting with other viruses and microorganisms.
상기한 발명의 기술적인 과제를 해결하기 위해 연구한 결과 본 발명자는 리얼타임 PCR을 이용하여 코로나바이러스 N 유전자를 검출하는 검사법을 제공하여 효과적으로 코로나바이러스를 검출하는 것으로 목적을 이룰 수 있다. In order to solve the technical problem of the present invention, the inventors of the present invention have achieved an object of effectively detecting a coronavirus by providing a test method for detecting a coronavirus N gene using real-time PCR.
본 발명에 따르면, 리얼타임 PCR을 이용하여 검출되는 대상인 코로나바이러스를 정확하게 정량적으로 확인을 할 수 있고, 이로써 간단하고도 신속 정확하게 코로나바이러스의 존재 유무를 확인할 수 있다.According to the present invention, it is possible to accurately and quantitatively confirm coronavirus, which is a target to be detected using real-time PCR, so that the presence or absence of corona virus can be confirmed simply and quickly.
도 1은 코로나바이러스의 형태학적, 유전적 구조를 나타내고 있다.Figure 1 shows the morphological and genetic structure of coronaviruses.
이하, 본 발명에 대해 상세하게 기술한다. 코로나바이러스 유전체 중 N 유전자를 표적으로 하여 한 쌍의 특이적인 프라이머로 PCR 방법을 이용하여 증폭하고 중폭된 산물에 교잡화하는 특이적인 형광프로브를 반응에 참여함으로써 증폭과정에서 교잡화된 프로브가 중합효소에 의해 분해되어 여기 형광이 발생하여 검출한다. Hereinafter, the present invention will be described in detail. A specific fluorescent probe that amplifies the N gene of the corona virus genome using PCR as a pair of specific primers and hybridizes to the heavy product is involved in the reaction so that the hybridized probe is amplified by polymerase And excitation fluorescence is generated and detected.
Claims (1)
한 쌍의 프라이머를 이용하여 N 유전자를 증폭하고, 하나의 형광프로브가 증폭산물과 교잡화하여 분해될 때 형광값을 확인하는 방법을 이용한 검사방법.As a corona virus test kit using real-time PCR,
Amplification of the N gene using a pair of primers, and hybridization of one fluorescent probe with the amplification product to confirm the fluorescence value when degraded.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170162353A KR20190063512A (en) | 2017-11-30 | 2017-11-30 | Method and kit for diagnosis coronavirus using real-time PCR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170162353A KR20190063512A (en) | 2017-11-30 | 2017-11-30 | Method and kit for diagnosis coronavirus using real-time PCR |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190063512A true KR20190063512A (en) | 2019-06-10 |
Family
ID=66848049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170162353A KR20190063512A (en) | 2017-11-30 | 2017-11-30 | Method and kit for diagnosis coronavirus using real-time PCR |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190063512A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102236568B1 (en) | 2020-07-07 | 2021-04-19 | 주식회사 쉐어플러스 | The uncontact specimen collection system to use smart device |
KR102247756B1 (en) | 2020-08-20 | 2021-06-03 | 주식회사 쉐어플러스 | walk-through screening clinic with smart function |
KR102264483B1 (en) | 2020-07-07 | 2021-06-17 | 주식회사 쉐어플러스 | The movable uncontact specimen collection booth |
KR102267326B1 (en) | 2020-03-24 | 2021-06-22 | 주식회사 젠큐릭스 | Method and kit for detecting coronavirus |
KR102295044B1 (en) | 2021-03-03 | 2021-08-27 | (주)젠에이치플러스 | Mask for collecting non-face-to-face virus and method for collecting non-face-to-face virus using the same |
KR102295049B1 (en) | 2021-03-03 | 2021-08-27 | (주)젠에이치플러스 | Non-face-to-face virus collection mask and method to measure the presence or absence of virus infection using it |
KR20220102595A (en) | 2021-01-13 | 2022-07-20 | 에이비온 주식회사 | Prophylactic administration for respiratory virus comprising administrating interferon beta to a subject potentially infected by respiratory virus |
-
2017
- 2017-11-30 KR KR1020170162353A patent/KR20190063512A/en unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102267326B1 (en) | 2020-03-24 | 2021-06-22 | 주식회사 젠큐릭스 | Method and kit for detecting coronavirus |
KR102236568B1 (en) | 2020-07-07 | 2021-04-19 | 주식회사 쉐어플러스 | The uncontact specimen collection system to use smart device |
KR102264483B1 (en) | 2020-07-07 | 2021-06-17 | 주식회사 쉐어플러스 | The movable uncontact specimen collection booth |
KR102247756B1 (en) | 2020-08-20 | 2021-06-03 | 주식회사 쉐어플러스 | walk-through screening clinic with smart function |
KR20220102595A (en) | 2021-01-13 | 2022-07-20 | 에이비온 주식회사 | Prophylactic administration for respiratory virus comprising administrating interferon beta to a subject potentially infected by respiratory virus |
WO2022154542A1 (en) | 2021-01-13 | 2022-07-21 | 에이비온 주식회사 | Prophylactic administration method against respiratory virus, comprising administering interferon-beta to potential respiratory virus-infected subject |
KR102295044B1 (en) | 2021-03-03 | 2021-08-27 | (주)젠에이치플러스 | Mask for collecting non-face-to-face virus and method for collecting non-face-to-face virus using the same |
KR102295049B1 (en) | 2021-03-03 | 2021-08-27 | (주)젠에이치플러스 | Non-face-to-face virus collection mask and method to measure the presence or absence of virus infection using it |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190063512A (en) | Method and kit for diagnosis coronavirus using real-time PCR | |
Chaijarasphong et al. | Potential application of CRISPR-Cas12a fluorescence assay coupled with rapid nucleic acid amplification for detection of white spot syndrome virus in shrimp | |
Quyen et al. | Classification of multiple DNA dyes based on inhibition effects on real-time loop-mediated isothermal amplification (LAMP): prospect for point of care setting | |
Meagher et al. | Impact of primer dimers and self-amplifying hairpins on reverse transcription loop-mediated isothermal amplification detection of viral RNA | |
Wolk et al. | PCR–electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories | |
Palaz et al. | CRISPR-based tools: Alternative methods for the diagnosis of COVID-19 | |
Euler et al. | Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents | |
Mannion et al. | Emerging technologies for the rapid detection of enteric viruses in the aquatic environment | |
Li et al. | Cas12aFDet: A CRISPR/Cas12a-based fluorescence platform for sensitive and specific detection of Listeria monocytogenes serotype 4c | |
Uphoff et al. | Detection of Mycoplasma contamination in cell cultures | |
Whiley et al. | Detection of novel influenza A (H1N1) virus by real-time RT-PCR | |
Ng et al. | Discovery of a novel single-stranded DNA virus from a sea turtle fibropapilloma by using viral metagenomics | |
Lee et al. | Molecular viability testing of viable but non‐culturable bacteria induced by antibiotic exposure | |
Papić et al. | New approaches on quantification of Campylobacter jejuni in poultry samples: the use of digital PCR and real-time PCR against the ISO standard plate count method | |
Manso et al. | Efficient and unbiased metagenomic recovery of RNA virus genomes from human plasma samples | |
Zasada et al. | Isothermal DNA amplification combined with lateral flow dipsticks for detection of biothreat agents | |
JP2021529540A (en) | Modular visual nucleic acid detection using enzyme-based nanotechnology | |
US20190017084A1 (en) | Multiple stage isothermal enzymatic amplification | |
Li et al. | Rapid detection of orf virus by loop-mediated isothermal amplification based on the DNA polymerase gene | |
Soltany-Rezaee-Rad et al. | Comparison of SYBR Green and TaqMan real-time PCR methods for quantitative detection of residual CHO host-cell DNA in biopharmaceuticals | |
Bak et al. | Multiplex quantitative PCR for single-reaction genetically modified (GM) plant detection and identification of false-positive GM plants linked to Cauliflower mosaic virus (CaMV) infection | |
Yang et al. | RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant | |
Lim et al. | Highly sensitive in vitro diagnostic system of pandemic influenza A (H1N1) virus infection with specific microRNA as a biomarker | |
Almasi et al. | Colorimetric immunocapture reverse transcription loop-mediated isothermal amplification assay for rapid detection of the Potato virus Y | |
Niu et al. | Highly sensitive detection method for HV69-70del in SARS-CoV-2 alpha and omicron variants based on CRISPR/Cas13a |